Vivos (RDGL) Receivables - Other (2010 - 2017)
Vivos' (RDGL) quarterly Receivables - Other came in at $137000.0 in Q4 2017, up 7.42% year-on-year from $127533.0 in Q4 2016, and little changed quarter-over-quarter from $137000.0 in Q3 2017.
Vivos (RDGL) Receivables - Other (2010 - 2017) Analysis & Trends
Vivos has disclosed Receivables - Other across 4 years of filings, most recently posting $137000.0 for Q4 2017.
- Receivables - Other for Q4 2017 came in at $137000.0, up 7.42% year-over-year; the trailing twelve-month figure through Dec 2017 was $137000.0 (up 7.42% YoY), and the FY2017 annual result was $137000.0, up 7.42% from the prior year.
- Receivables - Other came in at $137000.0 for Q4 2017 at Vivos, roughly flat from $137000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $137000.0 in Q1 2017 to a low of $127533.0 in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Vivos | - | - | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 137,000.00 |
| Dec 31, 2017 | 137,000.00 |
| Sep 30, 2017 | 137,000.00 |
| Sep 30, 2017 | 137,000.00 |
| Jun 30, 2017 | 137,000.00 |
| Jun 30, 2017 | 137,000.00 |
| Mar 31, 2017 | 137,000.00 |
| Mar 31, 2017 | 137,000.00 |
| Dec 31, 2016 | 127,533.00 |
| Dec 31, 2016 | 127,533.00 |
| Jun 30, 2011 | 125,000.00 |
| Jun 30, 2011 | 125,000.00 |
| Dec 31, 2010 | 425,504.00 |
| Dec 31, 2010 | 425,504.00 |